METHODS
We conducted a brief survey across the registry's existing clinical care Network. A web survey tool Survey Gizmo [http://www.surveygizmo.com] was used to facilitate the survey.
RESULTS
The survey was circulated to all existing CNDR Investigators and other key contacts, including genetic and metabolic clinic contacts, that were known to the CNDR in the Spring of 2014. Based on per clinic incident and followed cases, we estimate the total number of cases within our existing network to be between 20 and 120. Strong evidence exists that many cases are seen and/or diagnosed in metabolic clinics operating separately from specialty neuromuscular clinics. There was very little consensus on what dataset items should be collected in a registry dataset.
CONCLUSIONS
Willingness to collect data on Pompe disease patients in the registry network is high; however, the addition of genetic and metabolic clinics in some regions will be necessary to ensure that all Pompe disease *Correspondence to: Lawrence Korngut, Department of Clinical Neurosciences, University of Calgary Hotchkiss Brain Institute, Calgary T2N 1N4, Canada. E-mail: korngut@gmail.com.
